Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate.

Pediatrics
Peter W StacpooleJonathan J Shuster

Abstract

The purpose of this research was to report results on long-term administration of dichloroacetate in 36 children with congenital lactic acidosis who participated previously in a controlled trial of this drug. We conducted a randomized control trial, followed by an open-label study. Data were analyzed for each patient from the time they began treatment through May 2005. Subject exposure to dichloroacetate totaled 110.42 years. Median height and weight increased over time, but the standardized values declined slightly and remained below the first percentile. There were no significant changes in biochemical metabolic indices, except for a 2% rise in total protein and a 22% increase in 24-hour urinary oxalate. Both the basal and carbohydrate meal-induced rises in lactate were blunted by dichloroacetate. The median cerebrospinal fluid lactate also decreased over time. Conduction velocity decreased and distal latency increased in peroneal nerves. Mean 3-year survival for all of the subjects was 79%. Oral dichloroacetate is generally well tolerated in young children with congenital lactic acidosis. Although continued dichloroacetate exposure is associated with evidence of peripheral neuropathy, it cannot be determined whether this is ...Continue Reading

References

Jan 1, 1985·Clinical Pharmacology and Therapeutics·S H CurryP W Stacpoole
Mar 13, 1998·Archives of Disease in Childhood·P W StacpooleD S Kerr
Aug 26, 1998·Drug Metabolism Reviews·P W StacpooleM O James
Feb 7, 2006·Pediatric Neurology·David E SticklerPeter W Stacpoole
Apr 4, 2006·Biochemical Pharmacology·Chantale LangloisRobert M Tanguay
May 10, 2006·Archives of Neurology·Petra KaufmannDarryl C De Vivo
May 27, 2006·Mitochondrion·Kristen BerendzenPeter W Stacpoole
Jan 24, 2007·Journal of Neurochemistry·Natalia FelitsynLucia Notterpek

❮ Previous
Next ❯

Citations

May 27, 2010·Cancer Chemotherapy and Pharmacology·Dirk HesheClaudia Lanvers-Kaminsky
Dec 17, 2008·Current Neurology and Neuroscience Reports·Louis H Weimer, Noor Sachdev
Oct 5, 2013·Experimental & Molecular Medicine·Miran JangJinhwa Lee
May 14, 2010·Science Translational Medicine·E D MichelakisK C Petruk
Mar 8, 2013·Science Translational Medicine·Rosa FerrieroNicola Brunetti-Pierri
Nov 15, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Marina OstroukhovaRafeul Alam
Aug 7, 2012·PloS One·Kasirajan AyyanathanHerbert Weissbach
Oct 5, 2010·Journal of Oncology·Dana F Flavin
Jul 3, 2013·Nature Reviews. Neurology·Gerald PfefferPatrick F Chinnery
May 6, 2009·Journal of Cancer Research and Clinical Oncology·S YeluriD G Jayne
Dec 19, 2012·Seminars in Pediatric Neurology·Suzanne Debrosse, Sumit Parikh
Sep 13, 2011·Brain & Development·Chitra PrasadAsuri N Prasad
May 25, 2011·Mitochondrion·Peter W Stacpoole
Aug 21, 2009·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Josef Finsterer
Feb 28, 2016·Fertility and Sterility·Nicole M FletcherGhassan M Saed
Nov 3, 2016·Journal of the American Society of Nephrology : JASN·Ramindhu GalgamuwaAngelo Theodoratos
Jun 10, 2010·International Journal of Cancer. Journal International Du Cancer·Luke H StockwinDianne L Newton
Oct 20, 2010·International Journal of Cancer. Journal International Du Cancer·Ioanna PapandreouNicholas C Denko
Feb 20, 2013·International Journal of Cancer. Journal International Du Cancer·Toshimitsu OhashiNorimitsu Inoue
Sep 17, 2013·Journal of Biochemical and Molecular Toxicology·Herbert W MaisenbacherPeter W Stacpoole
Oct 31, 2014·Annals of Clinical and Translational Neurology·Rosa FerrieroNicola Brunetti-Pierri
Dec 4, 2013·Investigational New Drugs·E M DunbarP W Stacpoole
Feb 18, 2015·Journal of Inherited Metabolic Disease·Katharina DanhauserFelix Distelmaier
Nov 26, 2008·Biochimica Et Biophysica Acta·Salvatore Dimauro, Pierre Rustin
Aug 27, 2014·Biochimica Et Biophysica Acta·Shyam Kankotia, Peter W Stacpoole
Apr 25, 2013·Molecular Genetics and Metabolism·Monica AbdelmalakPeter W Stacpoole
Oct 28, 2010·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Mateusz KwitniewskiAsta Juzeniene
May 5, 2016·Pharmacogenomics·Margaret O James, Peter W Stacpoole
Jul 21, 2016·Toxicological Research·Quangdon TranJongsun Park
Dec 7, 2016·Continuum : Lifelong Learning in Neurology·Mark A Tarnopolsky
Oct 16, 2016·International Journal of Immunopathology and Pharmacology·Jurate StanevičiūtėDonatas Stakišaitis
Dec 3, 2008·The Journal of Biological Chemistry·Changlu LiuTimothy W Lovenberg
Aug 30, 2017·World Journal of Clinical Oncology·Akbar KhanAnneke C Blackburn
Apr 20, 2012·The Cochrane Database of Systematic Reviews·Gerald PfefferPatrick F Chinnery
Aug 31, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Laura Martínez-PalmaPatricia Cassina
Feb 8, 2019·Pulmonary Circulation·Daniel GrinnanEdda Spiekerkoetter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.